Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > How low can it go…..

<< Previous

Bullboard Posts

Next >>

Comment by Pareto8020on Aug 02, 2024 7:27am

135 Views

Post# 36160129

RE:RE:RE:How low can it go…..

No revenue, no pending revenue, large expenses looming, ongoing wages, incompetent management, etc. and they can't raise money in the general market and if they could it's only going to be at 3 cents!

No wonder bankruptcy is mentioned in the same breath as SBM.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale